2 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 2 |
Follow Sequence LifeScience, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers. Activate™ Matrix + SOC, AmnioDefend™ FT Matrix + SOC, Palisade™ DM Matrix + SOC - Skin Ulcer, Pressure Ulcer (PU) | Phase 4 | Recruiting | Sequence LifeScience, Inc. | 2000 | 2026-01-28 | 2026-06-24 |
| Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy Activate™ Matrix, AmnioDefend™ FT Matrix, Palisade™ DM Matrix - Diabetic Foot Ulcer, DFU | Phase 4 | Recruiting | Sequence LifeScience, Inc. | 350 | 2025-07-11 | 2026-05-19 |
Ulcer (2) · Diabetic Foot (1) · Foot Ulcer (1) · Pressure Ulcer (1) · Skin Ulcer (1) · Wounds and Injuries (1)
United States (2)